ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leukemia Targeted Therapy Drugs Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-7A18953
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Leukemia Targeted Therapy Drugs Market Research Report 2024
BUY CHAPTERS

Global Leukemia Targeted Therapy Drugs Market Research Report 2026

Code: QYRE-Auto-7A18953
Report
2026-01-28
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis Pharms
Bristol–Myers Squibb
IL-Yang Pharms
Pfizer Inc
Takeda Oncology
Johnson & Johnson
Gilead Sciences
AbbVie
Genentech Inc
Sanofi
Amgen Inc
Roche
GlaxoSmithKline PLC
Astrazeneca plc
BeiGene Ltd
Eli Lilly
Merck
Johnson & Johnson

Leukemia Targeted Therapy Drugs Market Size

The global Leukemia Targeted Therapy Drugs market was valued at US$ 4618 million in 2025 and is anticipated to reach US$ 6949 million by 2032, at a CAGR of 6.1% from 2026 to 2032.

Leukemia Targeted Therapy Drugs Market

Leukemia Targeted Therapy Drugs Market

Leukemia targeted therapy drugs are specialized medications designed to treat leukemia by specifically targeting the molecular and genetic abnormalities that drive the growth of cancer cells. Unlike traditional chemotherapy, which affects both healthy and cancerous cells, targeted therapies focus on mechanisms such as inhibiting tyrosine kinases, blocking abnormal protein functions, or interfering with the cancer cell's ability to grow and divide. Common drugs include tyrosine kinase inhibitors like imatinib for chronic myeloid leukemia (CML) and monoclonal antibodies targeting specific leukemia markers. These therapies improve treatment outcomes by offering greater precision, fewer side effects, and enhanced efficacy, especially in patients with specific genetic mutations or biomarkers.
The North American market for Leukemia Targeted Therapy Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Leukemia Targeted Therapy Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Leukemia Targeted Therapy Drugs in Acute Myeloid Leukemia (AML) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Leukemia Targeted Therapy Drugs include Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Leukemia Targeted Therapy Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Leukemia Targeted Therapy Drugs. The Leukemia Targeted Therapy Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Leukemia Targeted Therapy Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Leukemia Targeted Therapy Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Leukemia Targeted Therapy Drugs Market Report

Report Metric Details
Report Name Leukemia Targeted Therapy Drugs Market
Accounted market size in 2025 US$ 4618 million
Forecasted market size in 2032 US$ 6949 million
CAGR 6.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Monoclonal Antibodies
  • Small-Molecule Drugs
Segment by Application
  • Acute Myeloid Leukemia (AML)
  • Chronic Myeloid Leukemia (CML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, Amgen, Roche, GlaxoSmithKline, AstraZeneca, BeiGene, Eli Lilly, Merck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Leukemia Targeted Therapy Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Leukemia Targeted Therapy Drugs Market growing?

Ans: The Leukemia Targeted Therapy Drugs Market witnessing a CAGR of 6.1% during the forecast period 2026-2032.

What is the Leukemia Targeted Therapy Drugs Market size in 2032?

Ans: The Leukemia Targeted Therapy Drugs Market size in 2032 will be US$ 6949 million.

Who are the main players in the Leukemia Targeted Therapy Drugs Market report?

Ans: The main players in the Leukemia Targeted Therapy Drugs Market are Novartis Pharms, Bristol-Myers Squibb, IL-Yang Pharms, Pfizer, Takeda Oncology, Johnson & Johnson, Gilead Sciences, Abbvie, Genentech, Sanofi, Amgen, Roche, GlaxoSmithKline, AstraZeneca, BeiGene, Eli Lilly, Merck

What are the Application segmentation covered in the Leukemia Targeted Therapy Drugs Market report?

Ans: The Applications covered in the Leukemia Targeted Therapy Drugs Market report are Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL)

What are the Type segmentation covered in the Leukemia Targeted Therapy Drugs Market report?

Ans: The Types covered in the Leukemia Targeted Therapy Drugs Market report are Monoclonal Antibodies, Small-Molecule Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Monoclonal Antibodies
1.2.3 Small-Molecule Drugs
1.3 Market by Application
1.3.1 Global Leukemia Targeted Therapy Drugs Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Acute Myeloid Leukemia (AML)
1.3.3 Chronic Myeloid Leukemia (CML)
1.3.4 Acute Lymphoblastic Leukemia (ALL)
1.3.5 Chronic Lymphocytic Leukemia (CLL)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Leukemia Targeted Therapy Drugs Market Perspective (2021–2032)
2.2 Global Leukemia Targeted Therapy Drugs Growth Trends by Region
2.2.1 Global Leukemia Targeted Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Leukemia Targeted Therapy Drugs Historic Market Size by Region (2021–2026)
2.2.3 Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (2027–2032)
2.3 Leukemia Targeted Therapy Drugs Market Dynamics
2.3.1 Leukemia Targeted Therapy Drugs Industry Trends
2.3.2 Leukemia Targeted Therapy Drugs Market Drivers
2.3.3 Leukemia Targeted Therapy Drugs Market Challenges
2.3.4 Leukemia Targeted Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue
3.1.1 Global Top Leukemia Targeted Therapy Drugs Players by Revenue (2021–2026)
3.1.2 Global Leukemia Targeted Therapy Drugs Revenue Market Share by Players (2021–2026)
3.2 Global Top Leukemia Targeted Therapy Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Leukemia Targeted Therapy Drugs Revenue
3.4 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio
3.4.1 Global Leukemia Targeted Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leukemia Targeted Therapy Drugs Revenue in 2025
3.5 Global Key Players of Leukemia Targeted Therapy Drugs Head Offices and Areas Served
3.6 Global Key Players of Leukemia Targeted Therapy Drugs, Products and Applications
3.7 Global Key Players of Leukemia Targeted Therapy Drugs, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Leukemia Targeted Therapy Drugs Breakdown Data by Type
4.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Type (2021–2026)
4.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (2027–2032)
5 Leukemia Targeted Therapy Drugs Breakdown Data by Application
5.1 Global Leukemia Targeted Therapy Drugs Historic Market Size by Application (2021–2026)
5.2 Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Leukemia Targeted Therapy Drugs Market Size (2021–2032)
6.2 North America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
6.4 North America Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Leukemia Targeted Therapy Drugs Market Size (2021–2032)
7.2 Europe Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
7.4 Europe Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size (2021–2032)
8.2 Asia-Pacific Leukemia Targeted Therapy Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2021–2026)
8.4 Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Leukemia Targeted Therapy Drugs Market Size (2021–2032)
9.2 Latin America Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
9.4 Latin America Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size (2021–2032)
10.2 Middle East & Africa Leukemia Targeted Therapy Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2021–2026)
10.4 Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis Pharms
11.1.1 Novartis Pharms Company Details
11.1.2 Novartis Pharms Business Overview
11.1.3 Novartis Pharms Leukemia Targeted Therapy Drugs Introduction
11.1.4 Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.1.5 Novartis Pharms Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 IL-Yang Pharms
11.3.1 IL-Yang Pharms Company Details
11.3.2 IL-Yang Pharms Business Overview
11.3.3 IL-Yang Pharms Leukemia Targeted Therapy Drugs Introduction
11.3.4 IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.3.5 IL-Yang Pharms Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Leukemia Targeted Therapy Drugs Introduction
11.4.4 Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.4.5 Pfizer Recent Development
11.5 Takeda Oncology
11.5.1 Takeda Oncology Company Details
11.5.2 Takeda Oncology Business Overview
11.5.3 Takeda Oncology Leukemia Targeted Therapy Drugs Introduction
11.5.4 Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.5.5 Takeda Oncology Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Leukemia Targeted Therapy Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Leukemia Targeted Therapy Drugs Introduction
11.7.4 Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.7.5 Gilead Sciences Recent Development
11.8 Abbvie
11.8.1 Abbvie Company Details
11.8.2 Abbvie Business Overview
11.8.3 Abbvie Leukemia Targeted Therapy Drugs Introduction
11.8.4 Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.8.5 Abbvie Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Leukemia Targeted Therapy Drugs Introduction
11.9.4 Genentech Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.9.5 Genentech Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Leukemia Targeted Therapy Drugs Introduction
11.10.4 Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.10.5 Sanofi Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Leukemia Targeted Therapy Drugs Introduction
11.11.4 Amgen Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.11.5 Amgen Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Leukemia Targeted Therapy Drugs Introduction
11.12.4 Roche Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.12.5 Roche Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Leukemia Targeted Therapy Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.13.5 GlaxoSmithKline Recent Development
11.14 AstraZeneca
11.14.1 AstraZeneca Company Details
11.14.2 AstraZeneca Business Overview
11.14.3 AstraZeneca Leukemia Targeted Therapy Drugs Introduction
11.14.4 AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.14.5 AstraZeneca Recent Development
11.15 BeiGene
11.15.1 BeiGene Company Details
11.15.2 BeiGene Business Overview
11.15.3 BeiGene Leukemia Targeted Therapy Drugs Introduction
11.15.4 BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.15.5 BeiGene Recent Development
11.16 Eli Lilly
11.16.1 Eli Lilly Company Details
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Leukemia Targeted Therapy Drugs Introduction
11.16.4 Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.16.5 Eli Lilly Recent Development
11.17 Merck
11.17.1 Merck Company Details
11.17.2 Merck Business Overview
11.17.3 Merck Leukemia Targeted Therapy Drugs Introduction
11.17.4 Merck Revenue in Leukemia Targeted Therapy Drugs Business (2021–2026)
11.17.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Novartis Pharms
Bristol–Myers Squibb
IL-Yang Pharms
Pfizer Inc
Takeda Oncology
Johnson & Johnson
Gilead Sciences
AbbVie
Genentech Inc
Sanofi
Amgen Inc
Roche
GlaxoSmithKline PLC
Astrazeneca plc
BeiGene Ltd
Eli Lilly
Merck
Johnson & Johnson
List of Tables
 Table 1. Global Leukemia Targeted Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Small-Molecule Drugs
 Table 4. Global Leukemia Targeted Therapy Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Leukemia Targeted Therapy Drugs Market Share by Region (2021–2026)
 Table 8. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Leukemia Targeted Therapy Drugs Market Share by Region (2027–2032)
 Table 10. Leukemia Targeted Therapy Drugs Market Trends
 Table 11. Leukemia Targeted Therapy Drugs Market Drivers
 Table 12. Leukemia Targeted Therapy Drugs Market Challenges
 Table 13. Leukemia Targeted Therapy Drugs Market Restraints
 Table 14. Global Leukemia Targeted Therapy Drugs Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Leukemia Targeted Therapy Drugs Market Share by Players (2021–2026)
 Table 16. Global Top Leukemia Targeted Therapy Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Leukemia Targeted Therapy Drugs Revenue, 2025
 Table 17. Ranking of Global Top Leukemia Targeted Therapy Drugs Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Leukemia Targeted Therapy Drugs Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Leukemia Targeted Therapy Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Leukemia Targeted Therapy Drugs, Products and Applications
 Table 21. Global Key Players of Leukemia Targeted Therapy Drugs, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Leukemia Targeted Therapy Drugs Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2021–2026)
 Table 25. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Type (2027–2032)
 Table 27. Global Leukemia Targeted Therapy Drugs Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2021–2026)
 Table 29. Global Leukemia Targeted Therapy Drugs Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Leukemia Targeted Therapy Drugs Revenue Market Share by Application (2027–2032)
 Table 31. North America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size by Country (US$ Million), 2027–2032
 Table 46. Novartis Pharms Company Details
 Table 47. Novartis Pharms Business Overview
 Table 48. Novartis Pharms Leukemia Targeted Therapy Drugs Product
 Table 49. Novartis Pharms Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 50. Novartis Pharms Recent Development
 Table 51. Bristol-Myers Squibb Company Details
 Table 52. Bristol-Myers Squibb Business Overview
 Table 53. Bristol-Myers Squibb Leukemia Targeted Therapy Drugs Product
 Table 54. Bristol-Myers Squibb Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 55. Bristol-Myers Squibb Recent Development
 Table 56. IL-Yang Pharms Company Details
 Table 57. IL-Yang Pharms Business Overview
 Table 58. IL-Yang Pharms Leukemia Targeted Therapy Drugs Product
 Table 59. IL-Yang Pharms Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 60. IL-Yang Pharms Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer Leukemia Targeted Therapy Drugs Product
 Table 64. Pfizer Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 65. Pfizer Recent Development
 Table 66. Takeda Oncology Company Details
 Table 67. Takeda Oncology Business Overview
 Table 68. Takeda Oncology Leukemia Targeted Therapy Drugs Product
 Table 69. Takeda Oncology Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 70. Takeda Oncology Recent Development
 Table 71. Johnson & Johnson Company Details
 Table 72. Johnson & Johnson Business Overview
 Table 73. Johnson & Johnson Leukemia Targeted Therapy Drugs Product
 Table 74. Johnson & Johnson Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 75. Johnson & Johnson Recent Development
 Table 76. Gilead Sciences Company Details
 Table 77. Gilead Sciences Business Overview
 Table 78. Gilead Sciences Leukemia Targeted Therapy Drugs Product
 Table 79. Gilead Sciences Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 80. Gilead Sciences Recent Development
 Table 81. Abbvie Company Details
 Table 82. Abbvie Business Overview
 Table 83. Abbvie Leukemia Targeted Therapy Drugs Product
 Table 84. Abbvie Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 85. Abbvie Recent Development
 Table 86. Genentech Company Details
 Table 87. Genentech Business Overview
 Table 88. Genentech Leukemia Targeted Therapy Drugs Product
 Table 89. Genentech Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 90. Genentech Recent Development
 Table 91. Sanofi Company Details
 Table 92. Sanofi Business Overview
 Table 93. Sanofi Leukemia Targeted Therapy Drugs Product
 Table 94. Sanofi Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 95. Sanofi Recent Development
 Table 96. Amgen Company Details
 Table 97. Amgen Business Overview
 Table 98. Amgen Leukemia Targeted Therapy Drugs Product
 Table 99. Amgen Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 100. Amgen Recent Development
 Table 101. Roche Company Details
 Table 102. Roche Business Overview
 Table 103. Roche Leukemia Targeted Therapy Drugs Product
 Table 104. Roche Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 105. Roche Recent Development
 Table 106. GlaxoSmithKline Company Details
 Table 107. GlaxoSmithKline Business Overview
 Table 108. GlaxoSmithKline Leukemia Targeted Therapy Drugs Product
 Table 109. GlaxoSmithKline Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 110. GlaxoSmithKline Recent Development
 Table 111. AstraZeneca Company Details
 Table 112. AstraZeneca Business Overview
 Table 113. AstraZeneca Leukemia Targeted Therapy Drugs Product
 Table 114. AstraZeneca Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 115. AstraZeneca Recent Development
 Table 116. BeiGene Company Details
 Table 117. BeiGene Business Overview
 Table 118. BeiGene Leukemia Targeted Therapy Drugs Product
 Table 119. BeiGene Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 120. BeiGene Recent Development
 Table 121. Eli Lilly Company Details
 Table 122. Eli Lilly Business Overview
 Table 123. Eli Lilly Leukemia Targeted Therapy Drugs Product
 Table 124. Eli Lilly Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 125. Eli Lilly Recent Development
 Table 126. Merck Company Details
 Table 127. Merck Business Overview
 Table 128. Merck Leukemia Targeted Therapy Drugs Product
 Table 129. Merck Revenue in Leukemia Targeted Therapy Drugs Business (US$ Million), 2021–2026
 Table 130. Merck Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Leukemia Targeted Therapy Drugs Picture
 Figure 2. Global Leukemia Targeted Therapy Drugs Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Leukemia Targeted Therapy Drugs Market Share by Type: 2025 vs 2032
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Small-Molecule Drugs Features
 Figure 6. Global Leukemia Targeted Therapy Drugs Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Leukemia Targeted Therapy Drugs Market Share by Application: 2025 vs 2032
 Figure 8. Acute Myeloid Leukemia (AML) Case Studies
 Figure 9. Chronic Myeloid Leukemia (CML) Case Studies
 Figure 10. Acute Lymphoblastic Leukemia (ALL) Case Studies
 Figure 11. Chronic Lymphocytic Leukemia (CLL) Case Studies
 Figure 12. Leukemia Targeted Therapy Drugs Report Years Considered
 Figure 13. Global Leukemia Targeted Therapy Drugs Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Leukemia Targeted Therapy Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Leukemia Targeted Therapy Drugs Market Share by Region: 2025 vs 2032
 Figure 16. Global Leukemia Targeted Therapy Drugs Market Share by Players in 2025
 Figure 17. Global Leukemia Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Leukemia Targeted Therapy Drugs Revenue in 2025
 Figure 19. North America Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
 Figure 21. United States Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
 Figure 25. Germany Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Leukemia Targeted Therapy Drugs Market Share by Region (2021–2032)
 Figure 33. China Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
 Figure 41. Mexico Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Leukemia Targeted Therapy Drugs Market Share by Country (2021–2032)
 Figure 45. Israel Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Leukemia Targeted Therapy Drugs Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Novartis Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 50. IL-Yang Pharms Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 51. Pfizer Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 52. Takeda Oncology Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 53. Johnson & Johnson Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 54. Gilead Sciences Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 55. Abbvie Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 56. Genentech Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 57. Sanofi Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 58. Amgen Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 59. Roche Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 60. GlaxoSmithKline Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 61. AstraZeneca Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 62. BeiGene Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 63. Eli Lilly Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 64. Merck Revenue Growth Rate in Leukemia Targeted Therapy Drugs Business (2021–2026)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Targeted Therapy Drugs for Leukemia Market Research Report 2024
Global Targeted Cancer Therapy Market Research Report 2024
Global Targeted Oncology Drugs Market Research Report 2024
Global Targeted Drug for Blood Cancers Market Research Report 2024
Global Targeted Drug for Leukemia Market Research Report 2024
Global Cancer Targeted Drug Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Drug Market Research Report 2025
Global Oncology Targeted Therapy Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Chemotherapy Drugs Market Research Report 2024
Global Personalized Cancer Medicine Market Research Report 2025
Global TKI for Chronic Myeloid Leukemia Market Research Report 2024
Global Anticancer Drugs Market Research Report 2025
Global Myelofibrosis Targeted Drug Market Research Report 2024
Global Chronic Myeloid Leukemia Treatment Drugs Market Research Report 2025
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Global Treatment for Accelerated Phase CML Market Research Report 2024
Imatinib Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions